Inhaled corticosteroids for chronic cough in adults

An empirical trial of low-dose inhaled corticosteroids is only recommended if the patient has other features suggestive of asthma, such as dyspnoea, chest tightness, wheeze, obstructed spirometry or elevated fractional exhaled nitric oxide (FeNO)Gibson, 2016.

For dosages of inhaled corticosteroids in asthma, see Inhaled corticosteroid–based inhalers available in Australia for asthma in adults and adolescents .

Review response after 2 to 4 weeks. If the cough responds, this does not necessarily indicate a diagnosis of asthma; testing for asthma should be undertaken. See Asthma diagnosis.